Accelerate your path in molecular diagnostics under IVD-Regulations.
The demands are increasing for fast identification of clinically relevant Oncology biomarkers and timely detection of multiple-infectious pathogens that can help to guide treatment decisions in Cancer care, Infectious diseases and other disease areas.
The IVD regulations will bring a positive change to the EU’s medical devices and in-house developed testing market with the aim to ensure a high level of protection of public health, patients and users.
We, Thermo Fisher Scientific, are committed to this goal and will support our customers and laboratories in their IVDR transition by providing CE-IVD solutions and support in-house developed tests (IHAs). With our ability to help ensure your compliance, supply consistency, validation, and scalability, we offer clarity and confidence on your IVDR transition journey.
Prepare for upcoming events and or catch up on previous ones to learn about our innovations, products, and service solutions.